Ultromics granted FDA Breakthrough Device Status

44
Ultromics granted FDA Breakthrough Device Status


Ultromics has gained FDA Breakthrough Device Designation for its AI-powered EchoGo Amyloidosis platform, which is speeding up diagnosis.



– Original Source link –